Breast Neoplasms: all 12,820 studies
Page 25 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer PatientsRecruitingNCT05350722Not applicable
- Comprehensive Outcomes for After Cancer HealthRecruitingNCT05349227Not applicable
- Prone Positioning CT Scan and Ultrasound Assessing Axillary Lymph Nodes in Patients With Breast Cancer Official Title: Evaluation of Axillary Lymph Nodes Using Prone Positioning Computed Tomography Scan and Ultrasound in Patients With Breast CancerRecruitingNCT05346510Not applicable
- Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast CancerRecruitingNCT05345860Not applicable
- EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast CancerRecruitingNCT05341492Early Phase 1
- Effectiveness of Cryotherapy Combined With Compression Therapy for Preventing Chemotherapy-induced Peripheral NeuropathyRecruitingNCT05341141Not applicable
- Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast CancerRecruitingNCT05334459
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruitingNCT05334069
- OFS in Premenopausal Node+ Breast Cancer With Low Genomic RiskRecruitingNCT05333328Phase 4
- Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)RecruitingNCT05332561Phase 2
- Effects of Online Yoga on the Quality of Life of Breast Cancer PatientsRecruitingNCT05327543Not applicable
- The Psychology Intervention on Disease Acceptance and Quality of Life in Breast Cancer PatientsRecruitingNCT05327153Not applicable
- Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer PatientsRecruitingNCT05326295
- Early InterventionNot yet recruitingNCT05326165Not applicable
- Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & PertuzumabRecruitingNCT05325632Phase 2
- Improving Comprehensive Care of Cancer PatientsRecruitingNCT05323409Not applicable
- HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine TherapyNot yet recruitingNCT05322720Phase 2
- Developing Breast (Cancer) OrganoidsRecruitingNCT05317221
- Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationRecruitingNCT05315700Phase 1/2
- Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACTRecruitingNCT05314114Not applicable
- Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsRecruitingNCT05313191Not applicable
- Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast CancerRecruitingNCT05307757
- Breast CANcer Risk Assessment in Younger Women: BCAN-RAYRecruitingNCT05305963
- Implantation of CEST and CESL MRI Methods for Detection of Breast TumorsNot yet recruitingNCT05305937Not applicable
- Assessment of Brain Cognitive Impairment in Breast CancerRecruitingNCT05305092
- FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast CancerRecruitingNCT05304962Phase 1
- Eribulin as a Second-line Treatment in Triple-negative Advanced Breast CancerRecruitingNCT05302778
- A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions DetectionRecruitingNCT05300464Not applicable
- Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With CancerRecruitingNCT05297734Not applicable
- Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low RiskRecruitingNCT05297617Phase 2
- Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer TreatmentRecruitingNCT05297591
- Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast CancerRecruitingNCT05296577Phase 2
- A Post Marketing Surveillance on Piqray in KoreaRecruitingNCT05293470
- Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast CancerRecruitingNCT05292742Phase 2
- Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast CancerNot yet recruitingNCT05291910Phase 4
- Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound SystemRecruitingNCT05291507Early Phase 1
- Unified Barlow Protocol (UP) in Cancer Survivors for Cognitive ImpairmentsRecruitingNCT05289258Not applicable
- Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast CancerRecruitingNCT05288777Phase 2/3
- Efficacy of Talazoparib in Asian Metastatic Breast Cancer Patients With a Homologous Recombinant Deficiency (HRD) SignatureRecruitingNCT05288127Phase 2
- Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world StudyNot yet recruitingNCT05287308Not applicable
- Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant TherapyNot yet recruitingNCT05285332Not applicable
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Effect of the App Bone@BC Version 4.0 Under the Follow-up for Patients With Early Breast CancerNot yet recruitingNCT05280288Not applicable
- Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and PalbociclibRecruitingNCT05277935Not applicable
- A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast TissueRecruitingNCT05268224
- The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.RecruitingNCT05263570
- Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy PatientsNot yet recruitingNCT05253170Phase 3
- Safety and Feasibility of Robotic SP Nipple Sparing MastectomyRecruitingNCT05245812Not applicable
- Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone MetastasesRecruitingNCT05244382Not applicable
- Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening and Diagnosis of Breast CancerRecruitingNCT05243121
- Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy TreatmentNot yet recruitingNCT05241925Not applicable
- Axillary Lymph Node Treatment Guided by Naocarbon Tracing After Neoadjuvant ChemotherapyRecruitingNCT05241119Not applicable
- Validation of Scales in Reconstructive Breast SurgeryRecruitingNCT05233891
- Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsRecruitingNCT05232916Phase 3
- PARP-inhibitor on Advanced Metastatic Breast Cancer in Germline PALB2 Mutations CarriersNot yet recruitingNCT05232006Phase 2
- Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBCRecruitingNCT05228951Phase 2
- Effect of Breast Implants om Mammography ScreeningRecruitingNCT05222100
- Medical Imaging and Focused Ultrasound Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)RecruitingNCT05219695Phase 1
- Single Pre-Operative Radiation Therapy - With Delayed or No Surgery (SPORT-DNS)RecruitingNCT05217966Not applicable
- First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerRecruitingNCT05216432Phase 1
- Local and Regional Radiotherapy for Nipple Sparing Mastectomy With ImplantEnrolling by invitationNCT05213962
- Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High RisksRecruitingNCT05212454Phase 3
- TIL Relation to pCR After Neoadjuvant Therapy in Breast Cancer PatientsRecruitingNCT05206396
- Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02RecruitingNCT05205200Phase 2
- Non-Invasive Artificial Intelligence-Based Platform MonIToring Program (NIP IT!)RecruitingNCT05196087
- Randomized Feasibility Trial for Mesh in Pre-Pectoral ReconstructionRecruitingNCT05190978Not applicable
- Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.RecruitingNCT05190094Phase 2
- A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of AdultsEnrolling by invitationNCT05189717Phase 1
- Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast CancerRecruitingNCT05189067Phase 2/3
- A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast CancerRecruitingNCT05187832Phase 1
- An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast CancerRecruitingNCT05186545Phase 2
- LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New TechnologyRecruitingNCT05184790
- Physical Exercise During Preoperative Chemotherapy for Breast CancerRecruitingNCT05184582Not applicable
- Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With CancerRecruitingNCT05183126Phase 4
- Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 InhibitorRecruitingNCT05181033Phase 2
- Impact of Dietary Inflammatory Potential on Breast Cancer RiskRecruitingNCT05178498
- Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast CancerRecruitingNCT05177432Phase 1
- Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast CancerNot yet recruitingNCT05172518Phase 3
- A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDGEnrolling by invitationNCT05160480
- Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast CancerRecruitingNCT05159193Phase 3
- A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsRecruitingNCT05150691Phase 1/2
- A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free AnesthesiaRecruitingNCT05146778Not applicable
- Copenhagen Master Observational TrialRecruitingNCT05145244
- Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain OligometastasisRecruitingNCT05144867Phase 3
- Screening For BCRL In Targeted Therapy For Breast CancerRecruitingNCT05142800
- Magseed Pro(R)/ Sentimag(R) Gen3RecruitingNCT05142787Not applicable
- A Study of GC101 TIL in Advanced Breast Cancer (10hospital)RecruitingNCT05142475Early Phase 1
- Avera Cancer Sequencing and Analytics Protocol (ASAP)RecruitingNCT05142033
- Multidisciplinary Shared Decision Making of Fertility Preservation in Young Women With Breast CancerNot yet recruitingNCT05139641Not applicable
- Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009AvailableNCT05134922
- De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for YouRecruitingNCT05134779
- RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast CancerNot yet recruitingNCT05134519Phase 2
- Neoadjuvant Treatment of Breast CancerNot yet recruitingNCT05131893
- A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During SurgeryRecruitingNCT05130801Phase 1/2
- CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and TestingRecruitingNCT05130606Not applicable
- CTNNA1 Familial Expansion StudyRecruitingNCT05126290
- A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesRecruitingNCT05123482Phase 1/2
- Study of Screening Brain MRIs in Stage IV Breast CancerRecruitingNCT05115474Phase 2
- Predicting Effective Adaptation to Breast Cancer to Help Women to BOUNCE BackRecruitingNCT05095675
- Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerRecruitingNCT05095207Phase 1/2